Literature DB >> 9210604

Hepatitis C virus infection of salivary gland epithelial cells. Lack of evidence.

G Taliani1, D Celestino, M C Badolato, A Pennica, A Bozza, G Poliandri, V Riccieri, G Benfari, A Sebastiani, C De Bac, G Quaranta, A Aceti.   

Abstract

BACKGROUND: Hepatitis C virus genome (HCV-RNA) has been detected in whole salivary gland tissue of chronically infected patients. However, contamination of the tissue by plasma or blood cells was not excluded by the previous reports. AIMS: To assess whether HCV infects the salivary gland epithelial cells in patients with chronic HCV liver disease.
METHODS: Twenty unselected patients with chronic active hepatitis (11 cases) or active cirrhosis (nine cases) were examined. Serum and saliva samples were obtained from all patients, 12 of whom (seven, chronic active hepatitis; five, active cirrhosis) underwent salivary gland biopsy. PCR for HCV-RNA was performed on RNA extracted from serum, saliva and salivary gland epithelial cells collected by isokinetic gradient separation after trypsin digestion of whole salivary gland tissue. Saliva samples were also examined for the presence of secretory IgA anti-HCV by gel chromatography and ELISA testing.
RESULTS: HCV-RNA was detected in all sera with titers ranging from 5.42 x 10(5) genome equivalents/ml to 123.2 x 10(5) genome equivalents/ml. Thirteen patients were infected with genotype 1b, four patients had genotype 1a, two patients had genotype 2a and one patient was unclassifiable. Low titer HCV-RNA (<2 x 10(5) genome equivalents/ml) was detected in 3/20 saliva samples (15%) from highly viremic patients infected with 1b genotype. RNA extracted from salivary gland epithelial cells consistently tested negative for HCV-RNA. In addition, all saliva specimens tested negative for secretory-IgA (S-IgA) anti-HCV, even after a 10-fold concentration of the samples.
CONCLUSIONS: There was no evidence that HCV infects the salivary gland epithelial cells in our viremic patients with HCV chronic liver disease. Low level HCV-RNA in saliva is most probably due to virus spillover from blood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210604     DOI: 10.1016/s0168-8278(97)80452-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners.

Authors:  P Fabris; D Infantolino; M R Biasin; G Marchelle; E Venza; V Terribile Wiel Marin; P Benedetti; G Tositti; V Manfrin; F de Lalla
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

2.  Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients.

Authors:  Tetsuro Suzuki; Kazuhiko Omata; Tazuko Satoh; Takahiro Miyasaka; Chiaki Arai; Munehiro Maeda; Tomonori Matsuno; Tatsuo Miyamura
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.

Authors:  Fu-Ming Yan; An-Shen Chen; Fei Hao; Xi-Ping Zhao; Chang-Hai Gu; Li-Bin Zhao; Dong-Liang Yang; Lian-Jie Hao
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  In situ detection of hepatitis C virus RNA in salivary glands.

Authors:  J J Arrieta; E Rodríguez-Iñigo; N Ortiz-Movilla; J Bartolomé; M Pardo; F Manzarbeitia; H Oliva; D M Macías; V Carreño
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 5.  Oral manifestations of hepatitis C virus infection.

Authors:  Marco Carrozzo; Kara Scally
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 6.  Hepatitis C Infection and Periodontal Disease: Is there a Common Immunological Link?

Authors:  Dorin Nicolae Gheorghe; Liliana Foia; Vasilica Toma; Amelia Surdu; Elena Herascu; Dora Maria Popescu; Petra Surlin; Cristin Constantin Vere; Ion Rogoveanu
Journal:  J Immunol Res       Date:  2018-03-13       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.